This work aimed to evaluate the effect of a low CPS dose on the PD-L1 mRNA and protein expression in BC and RCC cell lines, along with the molecular mechanisms behind CPS-mediated immunomodulatory effects. This evidence concerns the gene CD274 and renal cell carcinoma.